Antianginal effects of FK409, a new spontaneous NO releaser
Open Access
- 1 December 1994
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 113 (4) , 1137-1140
- https://doi.org/10.1111/j.1476-5381.1994.tb17115.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Close correlation of the cardioprotective effect of FK409, a spontaneous NO releaser, with an increase in plasma cyclic GMP levelBritish Journal of Pharmacology, 1994
- Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409European Journal of Pharmacology, 1994
- Vasorelaxant mechanism of the new vasodilator, FK409European Journal of Pharmacology: Molecular Pharmacology, 1993
- Comparison of the effects of the novel vasodilator FK409 with those of nitroglycerin in isolated coronary artery of the dogBritish Journal of Pharmacology, 1991
- Characteristics of the Vasorelaxing Action of (3E)-4-Ethyl-2-Hydroximino-5-Nitro-3-Hexamide FK409, a New Vasodilator Isolated From Microbial Sources, in Isolated Rabbit ArteriesJournal of Cardiovascular Pharmacology, 1991
- Coronary artery spasm.1991
- FK409, a novel vasodilator isolated from the acid-treated fermentation broth of Streptomyces griseosporeus. I. Taxonomy, fermentation, isolation, and physico-chemical and biological characteristics.The Journal of Antibiotics, 1989
- Insights into the pathogenesis of acute ischemic syndromes.Circulation, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- ANTAGONIZING SUBSTANCES OBTAINED FROM WHALE HEART EXTRACT TO VASOPRESSIN INDUCED MYOCARDIAL HYPOXIAThe Japanese Journal of Pharmacology, 1970